Search Results - "Zacharioudaki, M."
-
1
Authentication of Greek Protected Designation of Origin cheeses through elemental metabolomics
Published in International dairy journal (01-05-2020)“…Greek Protected Designation of Origin (PDO) cheeses are characterised by high nutritional values and origin traits. The aim of the study was to determine the…”
Get full text
Journal Article -
2
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study
Published in International journal of antimicrobial agents (01-02-2020)“…•30-day all-cause mortality in Pseudomonas aeruginosa bacteraemia was high (26.5%).•Most risk factors for mortality are non-modifiable.•These include age, sex,…”
Get full text
Journal Article -
3
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study
Published in Clinical infectious diseases (23-05-2020)“…Abstract Background The optimal antibiotic regimen for Pseudomonas aeruginosa bacteremia is controversial. Although β-lactam monotherapy is common, data to…”
Get full text
Journal Article -
4
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Published in Journal of antimicrobial chemotherapy (01-08-2021)“…Abstract Background Pseudomonas aeruginosa bacteraemia is a common and serious infection. No consensus exists regarding whether definitive combination therapy…”
Get full text
Journal Article -
5
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
Published in Infection (01-08-2023)“…Background P. aeruginosa bacteremia is a common and severe infection carrying high mortality in older adults. We aimed to evaluate outcomes of P. aeruginosa…”
Get full text
Journal Article -
6
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Published in Infectious diseases and therapy (01-08-2022)“…Introduction There is no consensus regarding optimal duration of antibiotic therapy for Pseudomonas aeruginosa bacteremia. We aimed to evaluate the impact of…”
Get full text
Journal Article